Nurse Practitioner, Adult Health · Boston, MA
NPI
1245369925
Since 2007
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
Brigham & Women's Hospital, 221 Longwood Avenue Rfb 381
Boston, MA, 02115
Phone (617) 732-7672
Groups this clinician bills Medicare through
Medicare paid, 2024
$22K
192 services
Medicare patients, 2024
107
Average age 68
Drug cost, 2024
$5.0M
668 prescriptions
Company payments, 2025
$1,524
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Samira Sheth was code 99215 (office e&m - established), 182 times for 104 patients. In total Samira Sheth billed 192 services in 2 codes, and Medicare paid $22K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-09-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 182 | 104 | $115.26 | $21K |
By year: 2022 $4,812 for 70 services; 2023 $19K for 192 services; 2024 $22K for 192 services.
Medicare prescription drug claims, 2024
In 2024, the drug Samira Sheth prescribed most often to Medicare patients was Stelara (Ustekinumab), with 101 prescriptions and refills. In total Samira Sheth wrote 668 Medicare prescriptions that cost $5.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Stelara Ustekinumab | 101 | 129 | 22 | $2.6M |
| Mesalamine Generic | 69 | 159 | 29 | $56K |
| Skyrizi On-Body Risankizumab-Rzaa | 56 | 82 | 14 | $1.1M |
| Humira(Cf) Pen Adalimumab | 44 | 47 | Under 11 | $484K |
| Famotidine Generic | 37 | 74 | 13 | $2,438 |
| Omeprazole Generic | 28 | 70 | 17 | $375 |
| Rinvoq Upadacitinib | 18 | 18 | Under 11 | $145K |
| Mesalamine Er Mesalamine | 17 | 37 | Under 11 | $8,000 |
| Lactated Ringers Ringer's Solution,lactated | 16 | 16 | Under 11 | $210 |
| Loperamide Loperamide Hcl | 15 | 21 | Under 11 | $259 |
| Azathioprine Generic | 14 | 40 | Under 11 | $577 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 14 | 15 | Under 11 | $345 |
| Linzess Linaclotide | 14 | 24 | Under 11 | $14K |
| Entyvio Vedolizumab | 13 | 22 | Under 11 | $112K |
| Methotrexate Methotrexate Sodium | 11 | 29 | Under 11 | $472 |
Brand drugs: 358 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Samira Sheth $1,524 ($1,524 in general payments such as food, travel and fees) from 4 companies. The largest payer was Takeda Pharmaceuticals U.S.A., Inc. with $1,346.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.